Life science news 11 May 2026: M&A momentum, artificial intelligence diagnostics and a record week for deal-making define an active seven days for the global life science industry. The week of 4 to 10 May 2026 produced a dense cluster of major acquisitions, a...
GSK has entered into an exclusive licensing agreement with Chinese biotech Suzhou Siran Biotechnology (SiranBio), securing global rights to the company's early-stage small interfering RNA (siRNA) therapy, SA030, in a deal worth up to $1.005 billion in potential...
For the life sciences sector, the global nursing shortage is not a background public health concern. It is a clinical trial staffing problem, a pharmaceutical market access problem, and a real-world evidence problem. The WHO's 2025 State of the World's Nursing report...
Life science news 4 May 2026: Eli Lilly's record $19.8 billion quarterly earnings, the FDA's real-time clinical trial revolution and a landmark week for UK regulatory reform define a momentous seven days for global life science. Eli Lilly reported worldwide revenue of...
Precision medicine is no longer a futuristic concept. Genomic panels, pharmacogenomic testing, advanced biomarker analysis, and individualized risk stratification tools are all available today. Yet for the vast majority of patients walking into a primary care office,...
India's largest pharmaceutical company, Sun Pharmaceutical Industries, has agreed to acquire New Jersey-based Organon & Co. in an all-cash transaction valued at $11.75 billion, marking the largest acquisition ever undertaken by an Indian biopharmaceutical company....
Cholesterol-lowering drugs known as statins, taken by millions worldwide, are significantly safer than often perceived, according to a major new scientific analysis. Conducted by the Cholesterol Treatment Trialists’ (CTT) Collaboration and published in The Lancet, the...
Eli Lilly and Company has officially selected Fogelsville, Pennsylvania, as the site for its newest $3.5 billion injectable medicine and device manufacturing facility. Operating under the name "Lilly Lehigh Valley," the project represents the final piece of a quartet...
AstraZeneca has announced plans to invest up to 15 billion US dollars to expand its research, development, and manufacturing operations in China, reinforcing the country’s role as a central pillar of the company’s global strategy. The long-term investment will fund...
Phacilitate announces the return of Advanced Therapies Week (ATW) for its 22nd year, reinforcing its status as one of the most established and influential cell and gene therapy (CGT) conferences in the United States and among the most recognized globally. In...
New research published (22 January 2026) in The Lancet Psychiatry warn that lessons have not been learned from the pandemic when it comes to mental health. The researchers recommend that mental health should be treated as a core consideration when it comes to pandemic...
Thousands of men in England with advanced prostate cancer are set to gain access to a new life extending treatment following a decision by the National Institute for Health and Care Excellence. The move marks a significant development in the management of one of the...
Oxford Biomedica has officially confirmed it is in preliminary discussions with the Swedish private equity giant EQT regarding a potential cash takeover. The announcement follows significant market speculation and a sharp rise in the company’s share price on January...
In a move that signals a significant shift in the global pharmaceutical supply chain landscape, Thermo Fisher Scientific (NYSE: TMO) has announced a substantial influx of new contracts within its pharmaceutical services business. The common thread among these new...
Press Release: Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more...
The dream is always the same: strike out on your own and build something that’s truly yours. Perhaps you’re spinning out from a university, commercialising years of research with a fellow academic who shares your vision. Or maybe you’re breaking away from the big...
Leaders in life sciences and nuclear urge review of proposed changes Leaders across the science sector have made an urgent call to government to reconsider potentially harmful reforms to the way apprenticeships are assessed. Members of two leading employer bodies...
Dhruv Shenai explores how females have been left behind in conversations on autism by discussing the history and lack of female representation within the field. Neuroscientist Gina Rippon has spent years challenging the male-centred bias in autism research. Her new...